The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Acidex Oral SuspensionSodium Alginate 500mg,Sodium Bicarbonate 267mg,Calcium Carbonate 160mg/10ml

500mg+267mg+160 milligram/ 10 millilitre Oral suspension

Pinewood Laboratories Ltd,PA0281/075/001

Main Information

Trade NameAcidex Oral SuspensionSodium Alginate 500mg,Sodium Bicarbonate 267mg,Calcium Carbonate 160mg/10ml
Active SubstancesSodium alginate
Sodium bicarbonate
Calcium carbonate
Strength500mg+267mg+160 milligram/ 10 millilitre
Dosage FormOral suspension
Licence HolderPinewood Laboratories Ltd,
Licence NumberPA0281/075/001

Group Information

ATC CodeB05CB Salt solutions
B05CB04 sodium bicarbonate

Status

Authorised/WithdrawnAuthorised
Licence Issued26/06/1998
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back